United Theranostics

United Theranostics operates a growing national network of outpatient clinics providing FDA-approved radiopharmaceutical therapies for various cancers and access to clinical trials for new investigational radiopharmaceuticals. The company is expanding rapidly with plans to open up to eight new centers across the U.S. in 2025–2026. Its model integrates advanced molecular imaging with targeted therapy ("treat what you see and see what you treat"), focusing on patient-centric care. This profile is based strictly on available information from official websites and press releases as of June 2025. The company is an active private U.S.-based operator specializing in precision oncology through community-based clinics offering both commercialized and investigational radiotherapeutics integrated with advanced diagnostic imaging modalities.